Chris is an experienced geneticist, biochemist, and entrepreneur. He guided the acquisition of Knudra Transgenics by InVivo Biosystems. He participated in raising over $5 M in funding from venture capital. Achieved more than $7 M in non-dilutive funding from SBIRs. Licensed CRISPR technology in 2014 shortly after it was invented. Inventor on 20+ patents. Created more than 40 service product lines. Cultivated a sales and marketing team that achieved more than $10M in market revenue.